Updated Jul 16, 2026
Riva Alessandro has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $66K.

Riva Alessandro is identified in SEC filings as a director of BeOne Medicines Ltd. as of the most recent filing dated 2026-05-27. Public information about education, professional history, or other roles for this individual is limited in widely available sources. The available context indicates a governance role at BeOne Medicines Ltd., but detailed biographical information such as education, career trajectory, or achievements is not publicly documented within the provided SEC filing context.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | ONC | BeOne Medicines Ltd. | A — Grant or award | 19.0K | $0.00 | |
| 2026-05-27 | ONC | BeOne Medicines Ltd. | S — Open-market sale | 212 | $309.51 | $66K |
Riva Alessandro is identified in SEC filings as a director of BeOne Medicines Ltd. as of the most recent filing dated 2026-05-27. Public information about education, professional history, or other roles for this individual is limited in widely available sources. The available context indicates a governance role at BeOne Medicines Ltd., but detailed biographical information such…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($66K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Riva Alessandro profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.